MinshewB.Assays and antimicrobial susceptibility tests. Drug Ther1979; 8: 79–96.
2.
SyriopoulouVScheifeleDWSackCMSmithAL. Effect of inoculum size on the susceptibility of Haemophilus influenzae b to beta-lactam antibiotics. Antimicrob Agents Chemother1979; 16: 510–3.
3.
LevinRAzimiPDunphyM.Susceptibility of Haemophilus influenzae type b to cefaclor and influence of inoculum size. Antimicrob Agents Chemother1982; 22: 923–5.
4.
BulgerRWashingtonJ.Effects of inoculum size and β-lactamase production on in-vitro activity of new cephalosporins against Haemophilus species. Antimicrob Agents Chemother1980; 17: 393–6.
5.
SimardPBergeronM.Inoculum size effect on the MIC of cefoperazone, moxalactam, cefotaxime, cefoxitin, and cephalothin for 118 strains of Haemophilus influenzae including ‘tolerant’ microorganisms. J Antimicrob Chemother1982; 10: 397–402.
6.
CorradoMLandesmanSCherubinC.Influence of inoculum size on activity of cefoperazone, cefotaxime, moxalactam, piperacillin, and N-formimidoyl thienamycin (MK0787) againstPseudomonas aeruginosa. Antimicrob Agents Chemother1980; 18: 893–6.
7.
BaskerMEdmondsonRSutherlandR.Comparative antibacterial activity of azlocillin, mezlocillin, carbenicillin, and ticarcillin and relative stability to Beta-lactamases ofPseudomonas aeruginosa and Klebsiella aerogenes. Infection1979; 7: 67–73.